Pharma & Healthcare
Global Piroxicam Capsules Market Research Report 2026
- Mar 14, 26
- ID: 730422
- Pages: 119
- Figures: 127
- Views: 8
This report delivers a comprehensive overview of the global Piroxicam Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Piroxicam Capsules. The Piroxicam Capsules market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Piroxicam Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Piroxicam Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
SK Chemical
Pfizer
AdvaCare Pharma
Elikem Pharmaceuticals
DevLife
Nouvasant Group
Teva Pharmaceuticals USA
Baiyunshan
Chongqing Kerui Pharmaceutical
Guangdong Xinfeng Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Guangzhou Ouhua Pharmaceutica
Guangdong Pidi Pharmaceutical
Segment by Type
Regular Release
Modified Release
by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Piroxicam Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Piroxicam Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Piroxicam Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Piroxicam Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
SK Chemical
Pfizer
AdvaCare Pharma
Elikem Pharmaceuticals
DevLife
Nouvasant Group
Teva Pharmaceuticals USA
Baiyunshan
Chongqing Kerui Pharmaceutical
Guangdong Xinfeng Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Guangzhou Ouhua Pharmaceutica
Guangdong Pidi Pharmaceutical
Segment by Type
Regular Release
Modified Release
by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Piroxicam Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Piroxicam Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Piroxicam Capsules Market Overview
1.1 Product Definition
1.2 Piroxicam Capsules by Type
1.2.1 Global Piroxicam Capsules Market Value by Type: 2025 vs 2032
1.2.2 Regular Release
1.2.3 Modified Release
1.3 Piroxicam Capsules by Application
1.3.1 Global Piroxicam Capsules Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Piroxicam Capsules Market Size Estimates and Forecasts
1.4.1 Global Piroxicam Capsules Revenue 2021–2032
1.4.2 Global Piroxicam Capsules Sales 2021–2032
1.4.3 Global Piroxicam Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Piroxicam Capsules Market Competition by Manufacturers
2.1 Global Piroxicam Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Piroxicam Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Piroxicam Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Piroxicam Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Piroxicam Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Piroxicam Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Piroxicam Capsules, Date of Entry into the Industry
2.8 Global Piroxicam Capsules Market Competitive Situation and Trends
2.8.1 Global Piroxicam Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Piroxicam Capsules Players Market Share by Revenue
2.8.3 Global Piroxicam Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Piroxicam Capsules Market Scenario by Region
3.1 Global Piroxicam Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Piroxicam Capsules Sales by Region: 2021–2032
3.2.1 Global Piroxicam Capsules Sales by Region: 2021–2026
3.2.2 Global Piroxicam Capsules Sales by Region: 2027–2032
3.3 Global Piroxicam Capsules Revenue by Region: 2021–2032
3.3.1 Global Piroxicam Capsules Revenue by Region: 2021–2026
3.3.2 Global Piroxicam Capsules Revenue by Region: 2027–2032
3.4 North America Piroxicam Capsules Market Facts & Figures by Country
3.4.1 North America Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Piroxicam Capsules Sales by Country (2021–2032)
3.4.3 North America Piroxicam Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piroxicam Capsules Market Facts & Figures by Country
3.5.1 Europe Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Piroxicam Capsules Sales by Country (2021–2032)
3.5.3 Europe Piroxicam Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piroxicam Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Piroxicam Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Piroxicam Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Piroxicam Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Piroxicam Capsules Market Facts & Figures by Country
3.7.1 Latin America Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Piroxicam Capsules Sales by Country (2021–2032)
3.7.3 Latin America Piroxicam Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Piroxicam Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Piroxicam Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Piroxicam Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piroxicam Capsules Sales by Type (2021–2032)
4.1.1 Global Piroxicam Capsules Sales by Type (2021–2026)
4.1.2 Global Piroxicam Capsules Sales by Type (2027–2032)
4.1.3 Global Piroxicam Capsules Sales Market Share by Type (2021–2032)
4.2 Global Piroxicam Capsules Revenue by Type (2021–2032)
4.2.1 Global Piroxicam Capsules Revenue by Type (2021–2026)
4.2.2 Global Piroxicam Capsules Revenue by Type (2027–2032)
4.2.3 Global Piroxicam Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Piroxicam Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Piroxicam Capsules Sales by Application (2021–2032)
5.1.1 Global Piroxicam Capsules Sales by Application (2021–2026)
5.1.2 Global Piroxicam Capsules Sales by Application (2027–2032)
5.1.3 Global Piroxicam Capsules Sales Market Share by Application (2021–2032)
5.2 Global Piroxicam Capsules Revenue by Application (2021–2032)
5.2.1 Global Piroxicam Capsules Revenue by Application (2021–2026)
5.2.2 Global Piroxicam Capsules Revenue by Application (2027–2032)
5.2.3 Global Piroxicam Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Piroxicam Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 SK Chemical
6.1.1 SK Chemical Company Information
6.1.2 SK Chemical Description and Business Overview
6.1.3 SK Chemical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 SK Chemical Piroxicam Capsules Product Portfolio
6.1.5 SK Chemical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Piroxicam Capsules Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AdvaCare Pharma
6.3.1 AdvaCare Pharma Company Information
6.3.2 AdvaCare Pharma Description and Business Overview
6.3.3 AdvaCare Pharma Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AdvaCare Pharma Piroxicam Capsules Product Portfolio
6.3.5 AdvaCare Pharma Recent Developments/Updates
6.4 Elikem Pharmaceuticals
6.4.1 Elikem Pharmaceuticals Company Information
6.4.2 Elikem Pharmaceuticals Description and Business Overview
6.4.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio
6.4.5 Elikem Pharmaceuticals Recent Developments/Updates
6.5 DevLife
6.5.1 DevLife Company Information
6.5.2 DevLife Description and Business Overview
6.5.3 DevLife Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 DevLife Piroxicam Capsules Product Portfolio
6.5.5 DevLife Recent Developments/Updates
6.6 Nouvasant Group
6.6.1 Nouvasant Group Company Information
6.6.2 Nouvasant Group Description and Business Overview
6.6.3 Nouvasant Group Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nouvasant Group Piroxicam Capsules Product Portfolio
6.6.5 Nouvasant Group Recent Developments/Updates
6.7 Teva Pharmaceuticals USA
6.7.1 Teva Pharmaceuticals USA Company Information
6.7.2 Teva Pharmaceuticals USA Description and Business Overview
6.7.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio
6.7.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.8 Baiyunshan
6.8.1 Baiyunshan Company Information
6.8.2 Baiyunshan Description and Business Overview
6.8.3 Baiyunshan Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Baiyunshan Piroxicam Capsules Product Portfolio
6.8.5 Baiyunshan Recent Developments/Updates
6.9 Chongqing Kerui Pharmaceutical
6.9.1 Chongqing Kerui Pharmaceutical Company Information
6.9.2 Chongqing Kerui Pharmaceutical Description and Business Overview
6.9.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio
6.9.5 Chongqing Kerui Pharmaceutical Recent Developments/Updates
6.10 Guangdong Xinfeng Pharmaceutical
6.10.1 Guangdong Xinfeng Pharmaceutical Company Information
6.10.2 Guangdong Xinfeng Pharmaceutical Description and Business Overview
6.10.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio
6.10.5 Guangdong Xinfeng Pharmaceutical Recent Developments/Updates
6.11 Guangdong Zhongsheng Pharmaceutical
6.11.1 Guangdong Zhongsheng Pharmaceutical Company Information
6.11.2 Guangdong Zhongsheng Pharmaceutical Description and Business Overview
6.11.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio
6.11.5 Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
6.12 Guangzhou Ouhua Pharmaceutica
6.12.1 Guangzhou Ouhua Pharmaceutica Company Information
6.12.2 Guangzhou Ouhua Pharmaceutica Description and Business Overview
6.12.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio
6.12.5 Guangzhou Ouhua Pharmaceutica Recent Developments/Updates
6.13 Guangdong Pidi Pharmaceutical
6.13.1 Guangdong Pidi Pharmaceutical Company Information
6.13.2 Guangdong Pidi Pharmaceutical Description and Business Overview
6.13.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio
6.13.5 Guangdong Pidi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piroxicam Capsules Industry Chain Analysis
7.2 Piroxicam Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piroxicam Capsules Production Mode & Process Analysis
7.4 Piroxicam Capsules Sales and Marketing
7.4.1 Piroxicam Capsules Sales Channels
7.4.2 Piroxicam Capsules Distributors
7.5 Piroxicam Capsules Customer Analysis
8 Piroxicam Capsules Market Dynamics
8.1 Piroxicam Capsules Industry Trends
8.2 Piroxicam Capsules Market Drivers
8.3 Piroxicam Capsules Market Challenges
8.4 Piroxicam Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Piroxicam Capsules by Type
1.2.1 Global Piroxicam Capsules Market Value by Type: 2025 vs 2032
1.2.2 Regular Release
1.2.3 Modified Release
1.3 Piroxicam Capsules by Application
1.3.1 Global Piroxicam Capsules Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Piroxicam Capsules Market Size Estimates and Forecasts
1.4.1 Global Piroxicam Capsules Revenue 2021–2032
1.4.2 Global Piroxicam Capsules Sales 2021–2032
1.4.3 Global Piroxicam Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Piroxicam Capsules Market Competition by Manufacturers
2.1 Global Piroxicam Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Piroxicam Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Piroxicam Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Piroxicam Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Piroxicam Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Piroxicam Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Piroxicam Capsules, Date of Entry into the Industry
2.8 Global Piroxicam Capsules Market Competitive Situation and Trends
2.8.1 Global Piroxicam Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Piroxicam Capsules Players Market Share by Revenue
2.8.3 Global Piroxicam Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Piroxicam Capsules Market Scenario by Region
3.1 Global Piroxicam Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Piroxicam Capsules Sales by Region: 2021–2032
3.2.1 Global Piroxicam Capsules Sales by Region: 2021–2026
3.2.2 Global Piroxicam Capsules Sales by Region: 2027–2032
3.3 Global Piroxicam Capsules Revenue by Region: 2021–2032
3.3.1 Global Piroxicam Capsules Revenue by Region: 2021–2026
3.3.2 Global Piroxicam Capsules Revenue by Region: 2027–2032
3.4 North America Piroxicam Capsules Market Facts & Figures by Country
3.4.1 North America Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Piroxicam Capsules Sales by Country (2021–2032)
3.4.3 North America Piroxicam Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piroxicam Capsules Market Facts & Figures by Country
3.5.1 Europe Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Piroxicam Capsules Sales by Country (2021–2032)
3.5.3 Europe Piroxicam Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piroxicam Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Piroxicam Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Piroxicam Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Piroxicam Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Piroxicam Capsules Market Facts & Figures by Country
3.7.1 Latin America Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Piroxicam Capsules Sales by Country (2021–2032)
3.7.3 Latin America Piroxicam Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Piroxicam Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Piroxicam Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Piroxicam Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Piroxicam Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piroxicam Capsules Sales by Type (2021–2032)
4.1.1 Global Piroxicam Capsules Sales by Type (2021–2026)
4.1.2 Global Piroxicam Capsules Sales by Type (2027–2032)
4.1.3 Global Piroxicam Capsules Sales Market Share by Type (2021–2032)
4.2 Global Piroxicam Capsules Revenue by Type (2021–2032)
4.2.1 Global Piroxicam Capsules Revenue by Type (2021–2026)
4.2.2 Global Piroxicam Capsules Revenue by Type (2027–2032)
4.2.3 Global Piroxicam Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Piroxicam Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Piroxicam Capsules Sales by Application (2021–2032)
5.1.1 Global Piroxicam Capsules Sales by Application (2021–2026)
5.1.2 Global Piroxicam Capsules Sales by Application (2027–2032)
5.1.3 Global Piroxicam Capsules Sales Market Share by Application (2021–2032)
5.2 Global Piroxicam Capsules Revenue by Application (2021–2032)
5.2.1 Global Piroxicam Capsules Revenue by Application (2021–2026)
5.2.2 Global Piroxicam Capsules Revenue by Application (2027–2032)
5.2.3 Global Piroxicam Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Piroxicam Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 SK Chemical
6.1.1 SK Chemical Company Information
6.1.2 SK Chemical Description and Business Overview
6.1.3 SK Chemical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 SK Chemical Piroxicam Capsules Product Portfolio
6.1.5 SK Chemical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Piroxicam Capsules Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AdvaCare Pharma
6.3.1 AdvaCare Pharma Company Information
6.3.2 AdvaCare Pharma Description and Business Overview
6.3.3 AdvaCare Pharma Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AdvaCare Pharma Piroxicam Capsules Product Portfolio
6.3.5 AdvaCare Pharma Recent Developments/Updates
6.4 Elikem Pharmaceuticals
6.4.1 Elikem Pharmaceuticals Company Information
6.4.2 Elikem Pharmaceuticals Description and Business Overview
6.4.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio
6.4.5 Elikem Pharmaceuticals Recent Developments/Updates
6.5 DevLife
6.5.1 DevLife Company Information
6.5.2 DevLife Description and Business Overview
6.5.3 DevLife Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 DevLife Piroxicam Capsules Product Portfolio
6.5.5 DevLife Recent Developments/Updates
6.6 Nouvasant Group
6.6.1 Nouvasant Group Company Information
6.6.2 Nouvasant Group Description and Business Overview
6.6.3 Nouvasant Group Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nouvasant Group Piroxicam Capsules Product Portfolio
6.6.5 Nouvasant Group Recent Developments/Updates
6.7 Teva Pharmaceuticals USA
6.7.1 Teva Pharmaceuticals USA Company Information
6.7.2 Teva Pharmaceuticals USA Description and Business Overview
6.7.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio
6.7.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.8 Baiyunshan
6.8.1 Baiyunshan Company Information
6.8.2 Baiyunshan Description and Business Overview
6.8.3 Baiyunshan Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Baiyunshan Piroxicam Capsules Product Portfolio
6.8.5 Baiyunshan Recent Developments/Updates
6.9 Chongqing Kerui Pharmaceutical
6.9.1 Chongqing Kerui Pharmaceutical Company Information
6.9.2 Chongqing Kerui Pharmaceutical Description and Business Overview
6.9.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio
6.9.5 Chongqing Kerui Pharmaceutical Recent Developments/Updates
6.10 Guangdong Xinfeng Pharmaceutical
6.10.1 Guangdong Xinfeng Pharmaceutical Company Information
6.10.2 Guangdong Xinfeng Pharmaceutical Description and Business Overview
6.10.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio
6.10.5 Guangdong Xinfeng Pharmaceutical Recent Developments/Updates
6.11 Guangdong Zhongsheng Pharmaceutical
6.11.1 Guangdong Zhongsheng Pharmaceutical Company Information
6.11.2 Guangdong Zhongsheng Pharmaceutical Description and Business Overview
6.11.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio
6.11.5 Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
6.12 Guangzhou Ouhua Pharmaceutica
6.12.1 Guangzhou Ouhua Pharmaceutica Company Information
6.12.2 Guangzhou Ouhua Pharmaceutica Description and Business Overview
6.12.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio
6.12.5 Guangzhou Ouhua Pharmaceutica Recent Developments/Updates
6.13 Guangdong Pidi Pharmaceutical
6.13.1 Guangdong Pidi Pharmaceutical Company Information
6.13.2 Guangdong Pidi Pharmaceutical Description and Business Overview
6.13.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio
6.13.5 Guangdong Pidi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piroxicam Capsules Industry Chain Analysis
7.2 Piroxicam Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piroxicam Capsules Production Mode & Process Analysis
7.4 Piroxicam Capsules Sales and Marketing
7.4.1 Piroxicam Capsules Sales Channels
7.4.2 Piroxicam Capsules Distributors
7.5 Piroxicam Capsules Customer Analysis
8 Piroxicam Capsules Market Dynamics
8.1 Piroxicam Capsules Industry Trends
8.2 Piroxicam Capsules Market Drivers
8.3 Piroxicam Capsules Market Challenges
8.4 Piroxicam Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Piroxicam Capsules Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Piroxicam Capsules Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Piroxicam Capsules Market Competitive Situation by Manufacturers in 2025
Table 4. Global Piroxicam Capsules Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Piroxicam Capsules Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Piroxicam Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Piroxicam Capsules Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Piroxicam Capsules Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Piroxicam Capsules, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Piroxicam Capsules, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Piroxicam Capsules, Product Types and Applications
Table 12. Global Key Manufacturers of Piroxicam Capsules, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Piroxicam Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Piroxicam Capsules Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Piroxicam Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Piroxicam Capsules Sales by Region (K Units), 2021–2026
Table 18. Global Piroxicam Capsules Sales Market Share by Region (2021–2026)
Table 19. Global Piroxicam Capsules Sales by Region (K Units), 2027–2032
Table 20. Global Piroxicam Capsules Sales Market Share by Region (2027–2032)
Table 21. Global Piroxicam Capsules Revenue by Region (US$ Million), 2021–2026
Table 22. Global Piroxicam Capsules Revenue Market Share by Region (2021–2026)
Table 23. Global Piroxicam Capsules Revenue by Region (US$ Million), 2027–2032
Table 24. Global Piroxicam Capsules Revenue Market Share by Region (2027–2032)
Table 25. North America Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 27. North America Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 28. North America Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 29. North America Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 32. Europe Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 33. Europe Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Piroxicam Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Piroxicam Capsules Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Piroxicam Capsules Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Piroxicam Capsules Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Piroxicam Capsules Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 42. Latin America Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 43. Latin America Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 50. Global Piroxicam Capsules Sales (K Units) by Type (2021–2026)
Table 51. Global Piroxicam Capsules Sales (K Units) by Type (2027–2032)
Table 52. Global Piroxicam Capsules Sales Market Share by Type (2021–2026)
Table 53. Global Piroxicam Capsules Sales Market Share by Type (2027–2032)
Table 54. Global Piroxicam Capsules Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Piroxicam Capsules Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Piroxicam Capsules Revenue Market Share by Type (2021–2026)
Table 57. Global Piroxicam Capsules Revenue Market Share by Type (2027–2032)
Table 58. Global Piroxicam Capsules Price (US$/Unit) by Type (2021–2026)
Table 59. Global Piroxicam Capsules Price (US$/Unit) by Type (2027–2032)
Table 60. Global Piroxicam Capsules Sales (K Units) by Application (2021–2026)
Table 61. Global Piroxicam Capsules Sales (K Units) by Application (2027–2032)
Table 62. Global Piroxicam Capsules Sales Market Share by Application (2021–2026)
Table 63. Global Piroxicam Capsules Sales Market Share by Application (2027–2032)
Table 64. Global Piroxicam Capsules Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Piroxicam Capsules Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Piroxicam Capsules Revenue Market Share by Application (2021–2026)
Table 67. Global Piroxicam Capsules Revenue Market Share by Application (2027–2032)
Table 68. Global Piroxicam Capsules Price (US$/Unit) by Application (2021–2026)
Table 69. Global Piroxicam Capsules Price (US$/Unit) by Application (2027–2032)
Table 70. SK Chemical Company Information
Table 71. SK Chemical Description and Business Overview
Table 72. SK Chemical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. SK Chemical Piroxicam Capsules Product
Table 74. SK Chemical Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Piroxicam Capsules Product
Table 79. Pfizer Recent Developments/Updates
Table 80. AdvaCare Pharma Company Information
Table 81. AdvaCare Pharma Description and Business Overview
Table 82. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AdvaCare Pharma Piroxicam Capsules Product
Table 84. AdvaCare Pharma Recent Developments/Updates
Table 85. Elikem Pharmaceuticals Company Information
Table 86. Elikem Pharmaceuticals Description and Business Overview
Table 87. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Elikem Pharmaceuticals Piroxicam Capsules Product
Table 89. Elikem Pharmaceuticals Recent Developments/Updates
Table 90. DevLife Company Information
Table 91. DevLife Description and Business Overview
Table 92. DevLife Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. DevLife Piroxicam Capsules Product
Table 94. DevLife Recent Developments/Updates
Table 95. Nouvasant Group Company Information
Table 96. Nouvasant Group Description and Business Overview
Table 97. Nouvasant Group Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Nouvasant Group Piroxicam Capsules Product
Table 99. Nouvasant Group Recent Developments/Updates
Table 100. Teva Pharmaceuticals USA Company Information
Table 101. Teva Pharmaceuticals USA Description and Business Overview
Table 102. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Teva Pharmaceuticals USA Piroxicam Capsules Product
Table 104. Teva Pharmaceuticals USA Recent Developments/Updates
Table 105. Baiyunshan Company Information
Table 106. Baiyunshan Description and Business Overview
Table 107. Baiyunshan Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Baiyunshan Piroxicam Capsules Product
Table 109. Baiyunshan Recent Developments/Updates
Table 110. Chongqing Kerui Pharmaceutical Company Information
Table 111. Chongqing Kerui Pharmaceutical Description and Business Overview
Table 112. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product
Table 114. Chongqing Kerui Pharmaceutical Recent Developments/Updates
Table 115. Guangdong Xinfeng Pharmaceutical Company Information
Table 116. Guangdong Xinfeng Pharmaceutical Description and Business Overview
Table 117. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product
Table 119. Guangdong Xinfeng Pharmaceutical Recent Developments/Updates
Table 120. Guangdong Zhongsheng Pharmaceutical Company Information
Table 121. Guangdong Zhongsheng Pharmaceutical Description and Business Overview
Table 122. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product
Table 124. Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
Table 125. Guangzhou Ouhua Pharmaceutica Company Information
Table 126. Guangzhou Ouhua Pharmaceutica Description and Business Overview
Table 127. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product
Table 129. Guangzhou Ouhua Pharmaceutica Recent Developments/Updates
Table 130. Guangdong Pidi Pharmaceutical Company Information
Table 131. Guangdong Pidi Pharmaceutical Description and Business Overview
Table 132. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product
Table 134. Guangdong Pidi Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Piroxicam Capsules Distributors List
Table 138. Piroxicam Capsules Customers List
Table 139. Piroxicam Capsules Market Trends
Table 140. Piroxicam Capsules Market Drivers
Table 141. Piroxicam Capsules Market Challenges
Table 142. Piroxicam Capsules Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Piroxicam Capsules
Figure 2. Global Piroxicam Capsules Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Piroxicam Capsules Market Share by Type: 2025 & 2032
Figure 4. Regular Release Product Picture
Figure 5. Modified Release Product Picture
Figure 6. Global Piroxicam Capsules Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Piroxicam Capsules Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Global Piroxicam Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Piroxicam Capsules Market Size (US$ Million), 2021–2032
Figure 13. Global Piroxicam Capsules Sales (K Units), 2021–2032
Figure 14. Global Piroxicam Capsules Average Price (US$/Unit), 2021–2032
Figure 15. Piroxicam Capsules Report Years Considered
Figure 16. Piroxicam Capsules Sales Share by Manufacturers in 2025
Figure 17. Global Piroxicam Capsules Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Piroxicam Capsules Players: Market Share by Revenue in Piroxicam Capsules in 2025
Figure 19. Piroxicam Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Piroxicam Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 22. North America Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 23. United States Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 26. Europe Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 27. Germany Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Piroxicam Capsules Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Piroxicam Capsules Revenue Market Share by Region (2021–2032)
Figure 34. China Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 42. Latin America Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Piroxicam Capsules by Type (2021–2032)
Figure 53. Global Revenue Market Share of Piroxicam Capsules by Type (2021–2032)
Figure 54. Global Piroxicam Capsules Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Piroxicam Capsules by Application (2021–2032)
Figure 56. Global Revenue Market Share of Piroxicam Capsules by Application (2021–2032)
Figure 57. Global Piroxicam Capsules Price (US$/Unit) by Application (2021–2032)
Figure 58. Piroxicam Capsules Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Piroxicam Capsules Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Piroxicam Capsules Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Piroxicam Capsules Market Competitive Situation by Manufacturers in 2025
Table 4. Global Piroxicam Capsules Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Piroxicam Capsules Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Piroxicam Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Piroxicam Capsules Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Piroxicam Capsules Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Piroxicam Capsules, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Piroxicam Capsules, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Piroxicam Capsules, Product Types and Applications
Table 12. Global Key Manufacturers of Piroxicam Capsules, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Piroxicam Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Piroxicam Capsules Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Piroxicam Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Piroxicam Capsules Sales by Region (K Units), 2021–2026
Table 18. Global Piroxicam Capsules Sales Market Share by Region (2021–2026)
Table 19. Global Piroxicam Capsules Sales by Region (K Units), 2027–2032
Table 20. Global Piroxicam Capsules Sales Market Share by Region (2027–2032)
Table 21. Global Piroxicam Capsules Revenue by Region (US$ Million), 2021–2026
Table 22. Global Piroxicam Capsules Revenue Market Share by Region (2021–2026)
Table 23. Global Piroxicam Capsules Revenue by Region (US$ Million), 2027–2032
Table 24. Global Piroxicam Capsules Revenue Market Share by Region (2027–2032)
Table 25. North America Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 27. North America Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 28. North America Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 29. North America Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 32. Europe Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 33. Europe Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Piroxicam Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Piroxicam Capsules Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Piroxicam Capsules Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Piroxicam Capsules Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Piroxicam Capsules Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 42. Latin America Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 43. Latin America Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Piroxicam Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Piroxicam Capsules Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Piroxicam Capsules Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Piroxicam Capsules Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Piroxicam Capsules Revenue by Country (US$ Million), 2027–2032
Table 50. Global Piroxicam Capsules Sales (K Units) by Type (2021–2026)
Table 51. Global Piroxicam Capsules Sales (K Units) by Type (2027–2032)
Table 52. Global Piroxicam Capsules Sales Market Share by Type (2021–2026)
Table 53. Global Piroxicam Capsules Sales Market Share by Type (2027–2032)
Table 54. Global Piroxicam Capsules Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Piroxicam Capsules Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Piroxicam Capsules Revenue Market Share by Type (2021–2026)
Table 57. Global Piroxicam Capsules Revenue Market Share by Type (2027–2032)
Table 58. Global Piroxicam Capsules Price (US$/Unit) by Type (2021–2026)
Table 59. Global Piroxicam Capsules Price (US$/Unit) by Type (2027–2032)
Table 60. Global Piroxicam Capsules Sales (K Units) by Application (2021–2026)
Table 61. Global Piroxicam Capsules Sales (K Units) by Application (2027–2032)
Table 62. Global Piroxicam Capsules Sales Market Share by Application (2021–2026)
Table 63. Global Piroxicam Capsules Sales Market Share by Application (2027–2032)
Table 64. Global Piroxicam Capsules Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Piroxicam Capsules Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Piroxicam Capsules Revenue Market Share by Application (2021–2026)
Table 67. Global Piroxicam Capsules Revenue Market Share by Application (2027–2032)
Table 68. Global Piroxicam Capsules Price (US$/Unit) by Application (2021–2026)
Table 69. Global Piroxicam Capsules Price (US$/Unit) by Application (2027–2032)
Table 70. SK Chemical Company Information
Table 71. SK Chemical Description and Business Overview
Table 72. SK Chemical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. SK Chemical Piroxicam Capsules Product
Table 74. SK Chemical Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Piroxicam Capsules Product
Table 79. Pfizer Recent Developments/Updates
Table 80. AdvaCare Pharma Company Information
Table 81. AdvaCare Pharma Description and Business Overview
Table 82. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AdvaCare Pharma Piroxicam Capsules Product
Table 84. AdvaCare Pharma Recent Developments/Updates
Table 85. Elikem Pharmaceuticals Company Information
Table 86. Elikem Pharmaceuticals Description and Business Overview
Table 87. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Elikem Pharmaceuticals Piroxicam Capsules Product
Table 89. Elikem Pharmaceuticals Recent Developments/Updates
Table 90. DevLife Company Information
Table 91. DevLife Description and Business Overview
Table 92. DevLife Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. DevLife Piroxicam Capsules Product
Table 94. DevLife Recent Developments/Updates
Table 95. Nouvasant Group Company Information
Table 96. Nouvasant Group Description and Business Overview
Table 97. Nouvasant Group Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Nouvasant Group Piroxicam Capsules Product
Table 99. Nouvasant Group Recent Developments/Updates
Table 100. Teva Pharmaceuticals USA Company Information
Table 101. Teva Pharmaceuticals USA Description and Business Overview
Table 102. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Teva Pharmaceuticals USA Piroxicam Capsules Product
Table 104. Teva Pharmaceuticals USA Recent Developments/Updates
Table 105. Baiyunshan Company Information
Table 106. Baiyunshan Description and Business Overview
Table 107. Baiyunshan Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Baiyunshan Piroxicam Capsules Product
Table 109. Baiyunshan Recent Developments/Updates
Table 110. Chongqing Kerui Pharmaceutical Company Information
Table 111. Chongqing Kerui Pharmaceutical Description and Business Overview
Table 112. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product
Table 114. Chongqing Kerui Pharmaceutical Recent Developments/Updates
Table 115. Guangdong Xinfeng Pharmaceutical Company Information
Table 116. Guangdong Xinfeng Pharmaceutical Description and Business Overview
Table 117. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product
Table 119. Guangdong Xinfeng Pharmaceutical Recent Developments/Updates
Table 120. Guangdong Zhongsheng Pharmaceutical Company Information
Table 121. Guangdong Zhongsheng Pharmaceutical Description and Business Overview
Table 122. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product
Table 124. Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
Table 125. Guangzhou Ouhua Pharmaceutica Company Information
Table 126. Guangzhou Ouhua Pharmaceutica Description and Business Overview
Table 127. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product
Table 129. Guangzhou Ouhua Pharmaceutica Recent Developments/Updates
Table 130. Guangdong Pidi Pharmaceutical Company Information
Table 131. Guangdong Pidi Pharmaceutical Description and Business Overview
Table 132. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product
Table 134. Guangdong Pidi Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Piroxicam Capsules Distributors List
Table 138. Piroxicam Capsules Customers List
Table 139. Piroxicam Capsules Market Trends
Table 140. Piroxicam Capsules Market Drivers
Table 141. Piroxicam Capsules Market Challenges
Table 142. Piroxicam Capsules Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Piroxicam Capsules
Figure 2. Global Piroxicam Capsules Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Piroxicam Capsules Market Share by Type: 2025 & 2032
Figure 4. Regular Release Product Picture
Figure 5. Modified Release Product Picture
Figure 6. Global Piroxicam Capsules Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Piroxicam Capsules Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Global Piroxicam Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Piroxicam Capsules Market Size (US$ Million), 2021–2032
Figure 13. Global Piroxicam Capsules Sales (K Units), 2021–2032
Figure 14. Global Piroxicam Capsules Average Price (US$/Unit), 2021–2032
Figure 15. Piroxicam Capsules Report Years Considered
Figure 16. Piroxicam Capsules Sales Share by Manufacturers in 2025
Figure 17. Global Piroxicam Capsules Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Piroxicam Capsules Players: Market Share by Revenue in Piroxicam Capsules in 2025
Figure 19. Piroxicam Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Piroxicam Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 22. North America Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 23. United States Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 26. Europe Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 27. Germany Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Piroxicam Capsules Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Piroxicam Capsules Revenue Market Share by Region (2021–2032)
Figure 34. China Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 42. Latin America Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Piroxicam Capsules Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Piroxicam Capsules Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Piroxicam Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Piroxicam Capsules by Type (2021–2032)
Figure 53. Global Revenue Market Share of Piroxicam Capsules by Type (2021–2032)
Figure 54. Global Piroxicam Capsules Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Piroxicam Capsules by Application (2021–2032)
Figure 56. Global Revenue Market Share of Piroxicam Capsules by Application (2021–2032)
Figure 57. Global Piroxicam Capsules Price (US$/Unit) by Application (2021–2032)
Figure 58. Piroxicam Capsules Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232